Breaking News

Daily Archives: August 17, 2010

Lilly Halts Development of Semagacestat for Alzheimer’s Disease Based on Preliminary Results of Phase III Clinical Trials

INDIANAPOLIS, Aug. 17 /PRNewswire-AsiaNet/ — Decision does not affect other Lilly Alzheimer’s compounds in development Eli Lilly and Company (NYSE: LLY) will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer’s disease, because preliminary results from two ongoing long-term Phase III studies showed …

Read More »